Literature DB >> 16931039

The role of the BAFF/APRIL system on T cell function.

Fabienne Mackay1, Helen Leung.   

Abstract

BAFF is a key factor controlling B cell survival and maturation and its over-expression promotes B cell-mediated autoimmune disorders and participates in the progression of B cell lymphomas. Yet, BAFF and a related ligand APRIL are expressed by T lymphocytes and modulate their functions. BAFF and APRIL promote T cell activation and survival. BAFF over-expression in transgenic (Tg) mice enhances T helper 1 (Thl)-driven delayed-type hypersensitivity (DTH), but inhibits T helper 2 (Th2) cell-mediated allergic airway inflammation in mice. Some of these effects are also dependent on BAFF-induced modification of the B cell compartment. Therefore, direct BAFF/APRIL signalling in T cells and/or T cell modulation in response to a BAFF-modified B cell compartment may play an important role in inflammation and immunomodulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16931039     DOI: 10.1016/j.smim.2006.04.005

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  57 in total

1.  Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.

Authors:  Saravana K Kanagavelu; Victoria Snarsky; James M Termini; Sachin Gupta; Suzanne Barzee; Jacqueline A Wright; Wasif N Khan; Richard S Kornbluth; Geoffrey W Stone
Journal:  Vaccine       Date:  2011-12-04       Impact factor: 3.641

2.  TNF superfamily member 13, APRIL, inhibits allergic lung inflammation.

Authors:  Yanping Xiao; Seiichi Motomura; Vadim Deyev; Eckhard R Podack
Journal:  Eur J Immunol       Date:  2010-12-01       Impact factor: 5.532

Review 3.  Targeting BAFF in autoimmunity.

Authors:  Anne Davidson
Journal:  Curr Opin Immunol       Date:  2010-10-21       Impact factor: 7.486

4.  Blockade of BAFF Receptor BR3 on T Cells Enhances Their Activation and Cytotoxicity.

Authors:  Debra D Bloom; Sofiya Reshetylo; Cassandra Nytes; Claudia T Goodsett; Peiman Hematti
Journal:  J Immunother       Date:  2018-06       Impact factor: 4.456

5.  Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI.

Authors:  Amaya I Wolf; Krystyna Mozdzanowska; William J Quinn; Michele Metzgar; Katie L Williams; Andrew J Caton; Eric Meffre; Richard J Bram; Loren D Erickson; David Allman; Michael P Cancro; Jan Erikson
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

6.  BAFF blockade prevents anti-drug antibody formation in a mouse model of Pompe disease.

Authors:  Phillip A Doerfler; Sushrusha Nayak; Roland W Herzog; Laurence Morel; Barry J Byrne
Journal:  Clin Immunol       Date:  2015-04-01       Impact factor: 3.969

7.  B cell activating factor (BAFF) and a proliferation inducing ligand (APRIL) mediate CD40-independent help by memory CD4 T cells.

Authors:  V Gorbacheva; K Ayasoufi; R Fan; W M Baldwin; A Valujskikh
Journal:  Am J Transplant       Date:  2014-12-12       Impact factor: 8.086

8.  Safety, pharmacokinetics and pharmacodynamics of atacicept in healthy volunteers.

Authors:  Alain Munafo; Anthony Priestley; Ivan Nestorov; Jennifer Visich; Mark Rogge
Journal:  Eur J Clin Pharmacol       Date:  2007-05-01       Impact factor: 2.953

Review 9.  Cytokines and other mediators in alopecia areata.

Authors:  Stamatis Gregoriou; Dafni Papafragkaki; George Kontochristopoulos; Eustathios Rallis; Dimitrios Kalogeromitros; Dimitris Rigopoulos
Journal:  Mediators Inflamm       Date:  2010-03-11       Impact factor: 4.711

10.  Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets.

Authors:  Michael W Tusche; Lesley A Ward; Frances Vu; Doug McCarthy; Miguel Quintela-Fandino; Jurgen Ruland; Jennifer L Gommerman; Tak W Mak
Journal:  J Exp Med       Date:  2009-11-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.